INSERM - Institut National de la Santé et de la Recherche Médicale
发明人:
申请号：
EP11797324.8
公开号：
EP2652136B1
申请日:
2011.12.19
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The present invention concerns a TCTP antagonist, in particular a nucleic acid targeting an m RNA encoding Translationally-Controlled Tumor Protein (TCTP), wherein said nucleic acid is capable of reducing the amount of TCTP in cells, for use in the treatment or prevention of hormone-independent cancer or chemo-resistant cancer, such as an androgen-independent prostate cancer.
